Insider filing · MIRM
Peter Radovich
PRESIDENT AND COO
profile →
Mirum Pharmaceuticals, Inc.
MIRM · Healthcare · 60 filings in 24 months
ticker →
Peter Radovich sold $623K of Mirum Pharmaceuticals (MIRM)
Executed Mar 4 2025, disclosed Mar 5 2025, 1 day later.
Value, as filed
$623K
13,681 sh × $45.57
Executed
Mar 4 2025
the trade date, as filed
Disclosed
Mar 5 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PRPeter Radovich (PRESIDENT AND COO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $1.5M of MIRM (16,515 sh × $91.98, as filed), executed Mar 16.
The name
MIRMHealthcare · Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitat…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Peter Radovich in MIRM
MIRMSALE
Mirum Pharmaceuticals, Inc.
$1.5M16,515 sh × $91.98
Exec Mar 16
Filed Mar 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $272K
2,631 sh × $103.30
Exec Feb 2
Filed Feb 3 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $302K
3,143 sh × $96.19
Exec Jan 26
Filed Jan 27 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $222K
2,382 sh × $93.33
Exec Jan 22
Filed Jan 23 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $348K
7,879 sh × $44.21
Exec Mar 17 2025
Filed Mar 18 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $127K
2,627 sh × $48.22
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $152K
3,177 sh × $47.92
Exec Jan 24 2025
Filed Jan 27 2025 · 5:30 PM ET